BloodFlow
PrivateLast Round
Seed
Jul 25, 2025
Total Funding Raised
$1.4M
Company Overview
BloodFlow operates in Healthcare & Life Sciences and is based in Lisbon. Its latest recorded funding round was a Seed round in July 2025.
BloodFlow is a healthtech company that develops an AI-powered platform for automating and contextualizing the analysis of routine blood test results within hospital electronic health record systems.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BloodFlow Comparables
Compare BloodFlow with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Smart Blood Analytics Swiss SA | 78% | |
| Kahun | 74% | |
| Glass Health | 67% |
For institutional investors. Book with your work email.
BloodFlow Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BloodFlow Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3xP Global | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 75% QoQ, from 4 to 7 employees.
- Jul 25, 2025
$1.4M round led by 3xP Global
For institutional investors. Book with your work email.
BloodFlow Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BloodFlow's valuation, stock price, and market status.
Is BloodFlow a public or private company?
BloodFlow is a private company.
What is the current stock price of BloodFlow?
BloodFlow is a private company, so its shares have no public market price. Caplight tracks BloodFlow's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BloodFlow worth (valuation)?
Valuation information for BloodFlow is not publicly available.
Can I buy BloodFlow stock?
BloodFlow shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BloodFlow's last funding round?
BloodFlow's most recent funding round was Seed on July 25, 2025.
Who are the main investors in BloodFlow?
Key investors in BloodFlow include 3xP Global.
Will BloodFlow IPO soon?
No public IPO plans have been announced for BloodFlow.
How can I track BloodFlow secondary market activity?
Caplight tracks bids, offers, and trades in BloodFlow's shares on secondary markets.